Instant feedback + full explanation. One question, done properly.
HardHematologyPeriprocedural DOAC Managementmrcp part 1
A 24-year-old has severe alopecia areata with 72% scalp hair loss, major psychosocial impairment and no scarring alopecia. Infection screening is satisfactory, and specialist assessment finds no contraindication to an oral Janus kinase pathway treatment. Which option is commissioned by NICE for this indication?